ArticleTravel medicine and infectious disease
Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin.
Matthieu Million et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.